These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5085171)

  • 1. Chemical and biological aspects of the inhibition of red blood cell sickling by cyanate.
    Manning JM; Cerami A; Gillette PN; De Furia FG; Miller DR
    Adv Exp Med Biol; 1972; 28():253-60. PubMed ID: 5085171
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyanate as an inhibitor of red-cell sickling.
    Cerami A
    N Engl J Med; 1972 Oct; 287(16):807-12. PubMed ID: 4560520
    [No Abstract]   [Full Text] [Related]  

  • 3. Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
    Cerami A; Manning JM
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1180-3. PubMed ID: 5288366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urea, urease, cyanate, and the sickling of hemoglobin S.
    Nalbandian RM; Nichols BM; Stehouwer EJ; Camp FR
    Clin Chem; 1972 Sep; 18(9):961-4. PubMed ID: 5052097
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of urea and cyanate on sickling in vitro.
    Segel GB; Feig SA; Mentzer WC; McCaffrey RP; Wells R; Bunn HF; Shohet SB; Nathan DG
    N Engl J Med; 1972 Jul; 287(2):59-64. PubMed ID: 5031386
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyanate and sickle-cell disease.
    Cerami A; Peterson CM
    Sci Am; 1975 Apr; 232(4):44-50. PubMed ID: 1114310
    [No Abstract]   [Full Text] [Related]  

  • 7. Red cell survival of cyanate reacted sickle cells.
    Bellingham AJ; May A; Huehns ER
    Clin Sci; 1972 Apr; 42(4):21P. PubMed ID: 5020279
    [No Abstract]   [Full Text] [Related]  

  • 8. Deoxyhemoglobin S: solubility vs. erythrocyte sickling.
    Vedvick TS; Koenig HM; Itano HA
    Clin Biochem; 1975 Aug; 8(4):288-90. PubMed ID: 1157297
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxygen affinity independent action of cyanate and 2,3 DPG on sickling.
    Jensen MC; Bunn HF; Halikas GC; Nathan DG
    Adv Exp Med Biol; 1972; 28():297-302. PubMed ID: 5085173
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between the oxygen affinity and in vitro sickling propensity of carbamylated sickle erythrocytes.
    Diederich D
    Biochem Biophys Res Commun; 1972 Feb; 46(3):1255-61. PubMed ID: 5012168
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in morphological sickling of red cells incubated with quinine.
    Mankad VN; Moore RB
    Pediatr Hematol Oncol; 1987; 4(1):73-6. PubMed ID: 3152915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of the ektacytometer to automated continuous pO2 changes: determination of erythrocyte deformability in sickling disorders.
    Bessis M; Feo C; Jones E; Nossal M
    Cytometry; 1983 Jan; 3(4):296-9. PubMed ID: 6822150
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyanate effect on sickling.
    Charache S; Milner PF
    N Engl J Med; 1972 Dec; 287(26):1357-8. PubMed ID: 4635027
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical use of cyanate in sickling.
    Ranney HM
    N Engl J Med; 1972 Jul; 287(2):98-100. PubMed ID: 4624186
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of filterability of sickle cells by cyanate: an effect independent of oxygen saturation.
    Wagner SM; Bishop J; Flanigan PW; Bromberg PA; Balcerzak SP
    J Lab Clin Med; 1975 Mar; 85(3):445-50. PubMed ID: 1117207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamyl phosphate modification of hemoglobin S structure resulting in altered sickling.
    Kraus LM; Rasad A; Kraus AP
    Adv Exp Med Biol; 1972; 28():279-96. PubMed ID: 5085172
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia.
    De Furia FG; Miller DR; Cerami A; Manning JM
    J Clin Invest; 1972 Mar; 51(3):566-74. PubMed ID: 5011101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamyl phosphate mediated inhibition of the sickling of erythrocytes in vitro.
    Kraus LM; Kraus AP
    Biochem Biophys Res Commun; 1971 Sep; 44(6):1381-7. PubMed ID: 4946263
    [No Abstract]   [Full Text] [Related]  

  • 20. Sickle cell disease: advances in the 1970s and challenge in the 1980s.
    Bunn HF
    Am J Pediatr Hematol Oncol; 1982; 4(2):166-71. PubMed ID: 6180652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.